Septerna is a startup based in the United States, most recent round Series A, 4 tracked investors.
Based in the United States, Septerna is a startup. Its most recent tracked round is Series A. Brouky records 4 investors associated with the company.
drug target class of G protein-coupled receptors
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.